SCHEMBL1348616

SCHEMBL1348616

C=CCC(P)=C(CC=C)CC=C

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2241721 0.75 TSHR (0.43) TSHR
Ammonia Solution, Strong SCHEMBL8999729 0.72 TSHR (0.40) TSHR
SCHEMBL8231650 0.67 TSHR (0.44) TSHR
SCHEMBL8246115 0.65 TSHR (0.41) TSHR
SCHEMBL8230127 0.65 TSHR (0.33) TSHR
SCHEMBL1765025 0.62 TSHR (0.32) TSHR
SCHEMBL8844869 0.62 TSHR (0.35) TSHR
SCHEMBL235460 0.62 TSHR (0.32) TSHR
SCHEMBL9878846 0.62 TSHR (0.32) TSHR
SCHEMBL8254761 0.62 TSHR (0.32) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10266409-B1 Process for group III-V semiconductor nanostructure synthesis and compositions made using same NANOSYS, INC. (US) 2019-04-23 US claimed
US-8884273-B1 Process for group III-V semiconductor nanostructure synthesis and compositions made using same NANOSYS, INC. (US) 2014-11-11 US claimed
US-10266409-B1 Process for group III-V semiconductor nanostructure synthesis and compositions made using same NANOSYS, INC. (US) 2019-04-23 US disclosed
US-10029972-B2 Use of heteroleptic indium hydroxides as precursors for INP nanocrystals NANOSYS, INC. (US) 2018-07-24 US disclosed
US-9884763-B1 Process for group III-V semiconductor nanostructure synthesis and compositions made using same NANOSYS, INC. (US) 2018-02-06 US disclosed
US-9688534-B1 Process for group III-V semiconductor nanostructure synthesis and compositions made using same NANOSYS, INC. (US) 2017-06-27 US disclosed
US-20170137360-A1 USE OF HETEROLEPTIC INDIUM HYDROXIDES AS PRECURSORS FOR INP NANOCRYSTALS SHOEI CHEMICAL INC. (JP) 2017-05-18 US disclosed
WO-2017083483-A1 USE OF HETEROLEPTIC INDIUM HYDROXIDES AS PRECURSORS FOR INP NANOCRYSTALS NANOSYS, INC. (US) 2017-05-18 WO disclosed
US-9469538-B1 Process for group III-IV semiconductor nanostructure synthesis and compositions made using same NANOSYS, INC. (US) 2016-10-18 US disclosed
US-8884273-B1 Process for group III-V semiconductor nanostructure synthesis and compositions made using same NANOSYS, INC. (US) 2014-11-11 US disclosed
US-8062967-B1 Process for group III-V semiconductor nanostructure synthesis and compositions made using same NANOSYS, INC. (US) 2011-11-22 US disclosed
US-7557028-B1 For example, making indium phosphide (InP)semiconductors starting from tribenzoyl phosphine and tris-cyclopentadienyl indium; use in photovoltaic devices and light emitting diodes NANOSYS, INC. (US) 2009-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10029972-B2 Use of heteroleptic indium hydroxides as precursors for INP nanocrystals INPP5A, INPP5B, INPPL1 TSHR 4710/4885
US-20170137360-A1 USE OF HETEROLEPTIC INDIUM HYDROXIDES AS PRECURSORS FOR INP NANOCRYSTALS INPP5A, INPP5B, INPPL1 TSHR 4710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.